Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population

• Váldodahkkit: Yangguang Su (Dahkki), Ying Wang (Dahkki), Zhuo Qu (Dahkki), Jiaxin Liu (Dahkki), Xuekun Ren (Dahkki), Denan Zhang (Dahkki), Xiujie Chen (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction: Target therapy for cancer cell mutation has brought attention to several challenges in clinical applications, including limited therapeutic targets, less patient benefits, and susceptibility to acquired due to their clear biological mechanisms and high specificity in targeting cancers...